Postdoctoral Fellow - Epigenomic and Transcriptomic Research in Diabetes Complications
Job posting number: #7076488 (Ref:10009624-1)
Posted: March 29, 2021
Application Deadline: Open Until Filled
Job DescriptionThank you for your interest. Please note, the purpose of this posting is to recruit for on-going and future positions.
About City of Hope
City of Hope, an innovative biomedical research, treatment and educational institution with over 6,000 employees, is dedicated to the prevention and cure of cancer, type 1 diabetes, type 2 diabetes and other life-threatening diseases and guided by a compassionate, patient-centered philosophy.
City of Hope has one of the most influential type 1 and type 2 diabetes research programs in the world. Our scientists’ work has revolutionized the understanding and treatment of the disease and continues today with exciting developments in cell transplantation, gene regulation, immune tolerance and gaining systemic understanding of diabetes as a complex, multifaceted disease.
To learn more about our exciting research and accomplishments in the field of Diabetes, please visit https://www.cityofhope.org/research/diabetes-metabolism-research-institute
A Postdoctoral Fellow position is immediately available in the laboratory of Dr. Rama Natarajan, Professor and Chair, Department of Diabetes Complications, at the Diabetes and Metabolism Research Institute within Beckman Research Institute of City of Hope, California. The Natarajan laboratory is well recognized for research related to the molecular mechanisms associated with accelerated complications of diabetes, with specific emphasis on epigenetics and non-coding RNAs. The lab applies state-of-the-art transcriptomic (RNA-sequencing), and epigenomic profiling (DNA methylation, histone modifications, 3D chromatin), single cell sequencing, bioinformatics, molecular and cellular biology approaches in diabetes and obesity research, with a goal to unravel mechanisms underlying the accelerated rates of debilitating vascular complications in people with diabetes. Furthermore, we are exploring the epigenetic mechanisms associated with metabolic memory, a phenomenon in which prior episodes of hyperglycemia can lead to persistent development of complications despite subsequent glycemic control. We also test the translational potential of the new factors identified in our research by using novel targeting modalities in vivo. Together we adopt a unique comprehensive molecular-multi-Omics-translational approach using cell and animal models of diabetes as well as samples from subjects with diabetes.
We are seeking a highly motivated postdoctoral fellow with strong interest in epigenomic and transcriptomic research related to inflammatory, vascular and renal complications of diabetic complications. The candidate should have good training and technical expertise in molecular and cell biology, genomic data analyses and bioinformatics. The candidate should be self-motivated, with a proven track record of publications and strong interest to pursue diabetic complications research. Experience with animal models is a plus. The major interests in our lab include: 1) Role of epigenetics and non-coding RNAs in monocyte-macrophage inflammatory phenotypes in type1 and type2 diabetes; 2) Role of key lncRNAs in diabetic kidney disease. Development of genetic mouse models using CRISPR-Cas9 genome editing; 3) Epigenomics and gene regulation in diabetes induced vascular dysfunction and hypertension.
Basic education, experience and skills required for consideration:
- PhD in Molecular, Cellular or Developmental Biology.
- Proficiency with biochemical techniques, molecular biology skills and cell culture systems.
- Experience with epigenetics research, analyses of high throughput sequencing data and bioinformatics analysis required.
- Experience with in vivo animal model research is a plus, but not mandatory.
- Highly motivated with strong interest in diabetes/metabolic disease research.
- Strong work ethic and ability to work effectively in a team.
- For more information on Dr. Rama Natarajan please visit, https://www.cityofhope.org/people/natarajan-rama
- For a list of lab publications please visit,
- To apply, please provide your current CV, a brief research statement describing your background, experiences and career goals, and a list of three references
City of Hope is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, religion, color, national origin, sex, sexual orientation, gender identity, age, status as a protected veteran, or status as a qualified individual with disability.
City of Hope is a community of people characterized by our diversity of thought, background and approach, but tied together by our commitment to care for and cure those with cancer and other life-threatening diseases. The innovation that our diversity produces in the areas of research, treatment, philanthropy and education has made us national leaders in this fight. Our unique and diverse workforce provides us the ability to understand our patients' needs, deliver compassionate care and continue the quest for a cure for life-threatening diseases. At City of Hope, diversity and inclusion is a core value at the heart of our mission. We strive to create an inclusive workplace environment that engages all of our employees and provides them with opportunities to develop and grow, both personally and professionally. Each day brings an opportunity to strengthen our work, leverage our different perspectives and improve our patients’ experiences by learning from others. Diversity and inclusion is about much more than policies and campaigns. It is an integral part of who we are as an institution, how we operate and how we see our future.